Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...

Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network To evaluate morbidity, mortality, and overall and disease-free ...

Champions Oncology (NASDAQ: CSBR) today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft ® PDX models) in ...

Synovial sarcoma is an aggressive malignant tumor that primarily affects the limbs of teenagers and young adults. While it can be cured if completely removed by surgery, recurrence or metastasis, the ...

A research team at University of California, Los Angeles (UCLA), funded by Cancervax Inc., has created a promising new bispecific antibody vaccine for treating recurrent Ewing sarcoma. This treatment ...

In this retrospective analysis, outcomes data were evaluated on patients receiving care related to extrapleural pneumonectomy for soft tissue sarcoma or bone sarcoma. “Patient selection is critical ...

The optimal negative margin required following surgical resection and perioperative radiotherapy for extremity soft tissue sarcoma (STS) remains up for debate, with investigators of a new study using ...

Atypical fibroxanthoma (AFX) and its more aggressive counterpart, pleomorphic dermal sarcoma (PDS), constitute a spectrum of rare cutaneous neoplasms that chiefly affect elderly patients with a ...

Please provide your email address to receive an email when new articles are posted on . Five-year local recurrence rates were 10% and 17% for atypical fibroxanthoma and pleomorphic dermal sarcoma, ...

To evaluate morbidity, mortality, and overall and disease-free survival after surgical resection of primary and recurrent chest wall sarcomas, we performed a retrospective review of all patients with ...